Chest, Vol 94, 1232-1235, Copyright © 1988 by American College of Chest Physicians

ARTICLES

Cough capacity in patients with muscular dystrophy

A Szeinberg, E Tabachnik, N Rashed, FJ McLaughlin, S England, CA Bryan and H Levison
Department of Respiratory Physiology Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Cough capacity was evaluated in 22 patients with muscular dystrophy (MD) using subjective cough assessment, cough flow-volume curves, maximum expiratory pressures (MEP), forced vital capacity (FVC), and peak expiratory flow rates (PEFR). In ten of the 22 patients transients of peak flow were generated during cough flow-volume maneuvers, indicating dynamic compression of the airways, which is considered important in the physiology of an efficient cough. Patients who could not generate peak flow transients had significantly reduced PEFR, FVC, and MEP values. Measurement of MEP was the most sensitive predictor of flow transient production during coughing; all of the patients who exhibited transients had MEP values of above 60 cmH2O, whereas the highest value of MEP recorded in patients without transients was 45 cmH2O. Three of the 12 patients who were unable to generate flow transients were considered to have an adequate cough by subjective assessment. We concluded that the measurement of MEP is extremely useful for assessment of cough strength in patients with MD.

This article has been cited by other articles:

				D. J. Birnkrant, H. B. Panitch, J. O. Benditt, L. J. Boitano, E. R. Carter, V. A. Cwik, J. D. Finder, S. T. Iannaccone, L. E. Jacobson, G. L. Kohn, et al. American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation Chest, December 1, 2007; 132(6): 1977 - 1986. [Abstract] [Full Text] [PDF]

				Respiratory Care of the Patient with Duchenne Muscular Dystrophy: ATS Consensus Statement Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 456 - 465. [Full Text] [PDF]

				L. J. Miske, E. M. Hickey, S. M. Kolb, D. J. Weiner, and H. B. Panitch Use of the Mechanical In-Exsufflator in Pediatric Patients With Neuromuscular Disease and Impaired Cough Chest, April 1, 2004; 125(4): 1406 - 1412. [Abstract] [Full Text] [PDF]

				M.B. Chaudri, C. Liu, R. Hubbard, D. Jefferson, and W.J. Kinnear Relationship between supramaximal flow during cough and mortality in motor neurone disease Eur. Respir. J., March 1, 2002; 19(3): 434 - 438. [Abstract] [Full Text] [PDF]

				M. I. Polkey and J. Moxham Clinical Aspects of Respiratory Muscle Dysfunction in the Critically Ill Chest, March 1, 2001; 119(3): 926 - 939. [Full Text] [PDF]

				M. I Polkey, R. A Lyall, A C. Davidson, P N. Leigh, and J. Moxham Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease Thorax, April 1, 1999; 54(4): 367 - 371. [Full Text]

				M. I Polkey, R. A Lyall, J. Moxham, and P N. Leigh Respiratory aspects of neurological disease J. Neurol. Neurosurg. Psychiatry, January 1, 1999; 66(1): 5 - 15. [Full Text]

				M. I. POLKEY, R. A. LYALL, M. GREEN, P. NIGEL LEIGH, and J. MOXHAM Expiratory Muscle Function in Amyotrophic Lateral Sclerosis Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 734 - 741. [Abstract] [Full Text] [PDF]

				D. KYROUSSIS, M. I. POLKEY, G. H. MILLS, P. D. HUGHES, J. MOXHAM, and M. GREEN Simulation of Cough in Man by Magnetic Stimulation of the Thoracic Nerve Roots Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1696 - 1699. [Abstract] [Full Text]